Net Cash Provided by (Used in) Financing Activities of ABBOTT LABORATORIES from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ABBOTT LABORATORIES annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • ABBOTT LABORATORIES Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $2,055,000,000, a 75% decline year-over-year.
  • ABBOTT LABORATORIES annual Net Cash Provided by (Used in) Financing Activities for 2025 was $6,309,000,000, a 17% decline from 2024.
  • ABBOTT LABORATORIES annual Net Cash Provided by (Used in) Financing Activities for 2024 was $5,404,000,000, a 24% increase from 2023.
  • ABBOTT LABORATORIES annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7,091,000,000, a 7.1% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

ABBOTT LABORATORIES Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,309,000,000 -$905,000,000 -17% 01 Jan 2025 31 Dec 2025 10-K 20 Feb 2026 2025 FY
2024 $5,404,000,000 +$1,687,000,000 +24% 01 Jan 2024 31 Dec 2024 10-K 20 Feb 2026 2025 FY
2023 $7,091,000,000 +$545,000,000 +7.1% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2026 2025 FY
2022 $7,636,000,000 -$2,142,000,000 -39% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $5,494,000,000 -$2,715,000,000 -98% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024 2023 FY
2020 $2,779,000,000 +$1,510,000,000 +35% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023 2022 FY
2019 $4,289,000,000 +$6,102,000,000 +59% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022 2021 FY
2018 $10,391,000,000 -$5,110,000,000 -97% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021 2020 FY
2017 $5,281,000,000 -$16,428,000,000 -147% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020 2019 FY
2016 $11,147,000,000 +$13,383,000,000 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019 2018 FY
2015 $2,236,000,000 +$506,000,000 +18% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $2,742,000,000 +$3,954,000,000 +59% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $6,696,000,000 -$6,891,000,000 -3534% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016 2015 FY
2012 $195,000,000 +$6,618,000,000 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015 2014 FY
2011 $6,423,000,000 -$5,335,259,000 -490% 01 Jan 2011 31 Dec 2011 10-K 21 Feb 2014 2013 FY
2010 $1,087,741,000 01 Jan 2010 31 Dec 2010 10-K 18 Feb 2011 2010 FY

ABBOTT LABORATORIES Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $2,055,000,000 -$879,000,000 -75% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025 2025 Q1
Q1 2024 $1,176,000,000 +$234,000,000 +17% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025 2025 Q1
Q1 2023 $1,410,000,000 +$2,413,000,000 +63% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $3,823,000,000 -$2,856,000,000 -295% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $967,000,000 -$232,000,000 -32% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q1 2020 $735,000,000 +$407,000,000 +36% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $1,142,000,000 +$5,313,000,000 +82% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020 2020 Q1
Q1 2018 $6,455,000,000 -$2,056,000,000 -47% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019 2019 Q1
Q1 2017 $4,399,000,000 -$2,967,000,000 -207% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $1,432,000,000 -$882,000,000 -160% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $550,000,000 +$602,000,000 +52% 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2014 $1,152,000,000 +$3,581,000,000 +76% 01 Jan 2014 31 Mar 2014 10-Q 06 May 2015 2015 Q1
Q1 2013 $4,733,000,000 -$4,898,225,000 -2965% 01 Jan 2013 31 Mar 2013 10-Q 07 May 2014 2014 Q1
Q1 2012 $165,225,000 +$849,559,000 01 Jan 2012 31 Mar 2012 10-Q 08 May 2013 2013 Q1
Q1 2011 $684,334,000 -$164,135,000 -32% 01 Jan 2011 31 Mar 2011 10-Q 06 May 2011 2011 Q1
Q1 2010 $520,199,000 01 Jan 2010 31 Mar 2010 10-Q 06 May 2011 2011 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.